Efavirenz

Efavirenz has been studied in 3 papers since 2022: 2 observational studies in people, 1 review; 1 in the past year. The newest story, Oct 8, 2026: “Liver disease linked to cognitive decline in older Thais with HIV”.

3 papers study it10 more mention itUpdated Mar 27, 2026

PubChem ChEBI MeSH

Humans2

Latest

4 papers in 12 months

Journal of the International AIDS SocietyOct 8

Liver disease linked to cognitive decline in older Thais with HIV

In a study of older Thai people with HIV, cognitive scores fell 4.79 points in those with an inflammatory liver condition compared with 0.94 without.In a study of older Thai people with HIV, cognitive scores fell 4.79 points in those with an inflammatory liver condition compared with 0.94 without.

Cohort study of 291 peoplePopulations

Toxicology ReportsJul 2

Kaempferol from Moringa oleifera L. increases longevity and ameliorates efavirenz-induced functional senescence in Drosophila melanogaster

Experiments in fliesInterventions

The Lancet HIVMar 31

Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE

Cohort study of 5,114 peopleMajor adverse cardiovascular events

Frontiers in EpidemiologyMar 27

Vitamin D and the metabolic-associated steatotic liver disease-type 2 diabetes axis: a scoping-narrative review of global evidence and emerging perspectives for Sub-Saharan Africa

ReviewLipid and ceramide metabolism

Clinical PharmacokineticsNov 15

Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV, Part II: Drugs Licensed Before 2005

Systematic reviewMechanisms

PLOS BiologyAug 24

Phytosterols reverse antiretroviral-induced hearing loss, with potential implications for cochlear aging

Experiments in miceHearing loss

Journal of NeurovirologyDec 13

Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study

Cohort study in peopleNeurological disorders

HIV MedicineJul 22

Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial

Trial in peopleInterventions

Brain CommunicationsApr 24

Interactive effects of HIV and ageing on neural oscillations: independence from neuropsychological performance

Study in peopleMechanisms

AIDS Research and Human RetrovirusesOct 8

Short Communication: Carotid Intima-Media Thickness Is Not Associated with Neurocognitive Impairment Among People Older than 50 Years With and Without HIV Infection from Thailand

Study in peopleBiomarkers